Introduction
Chronic inflammatory demyelinating polyneuropathy (CIDP) and acute inflammatory demyelinating polyneuropathy (AIDP, a form of Guillain-Barre syndrome [GBS] ) are characterized by sensory impairment and disabling weakness (1, 2) and are the result of autoimmune demyelination of the PNS. Current therapies include plasmapheresis and intravenous Ig (IVIg) for CIDP and AIDP as well as corticosteroids for CIDP, all of which have nonspecific mechanisms of action and broadly suppress the immune system (3, 4) . Patients with CIDP often require long-term treatment in order to maintain therapeutic effect (3) , and even with these treatments, clinical remission is not achieved in approximately 30% of patients (5) . Thus, the development of novel, mechanism-based therapies is desirable and would be greatly aided by the delineation of pathogenic mechanisms.
Through the use of mouse models of inflammatory neuropathies and patients' biopsy samples, the immune mechanisms that contribute to the development of autoimmune peripheral neuropathy have been partially illuminated. The prominence of T cells and F4/80 + macrophages in affected nerves of spontaneous autoimmune peripheral polyneuropathy (SAPP) mice (6, 7) , experimental allergic neuritis (EAN) mice (8, 9) , and human patients (10, 11) suggests that these cells are particularly important. Further, in SAPP and EAN, CD4 + T cells isolated from neuropathic mice are sufficient to transfer disease to T and B cell-deficient (SCID) recipients, underscoring an important role for CD4 + T cells among lymphocytes (7, 12, 13) . Both Th1 and Th17 have been implicated in the pathogenesis of CIDP and GBS, since the frequency of Th1 and Th17 cells is elevated in the blood and cerebrospinal fluid (CSF) of patients (14, 15) , but the relative importance of Th1 and Th17 is still controversial. In models of SAPP, Th1 T cells predominate (7, 12) , but in EAN, an important role for Th17 has also been suggested (16) . Macrophages may also contribute to autoimmune destruction of the PNS, since macrophages in EAN exhibit an inflammatory phenotype, which includes the secretion of proinflammatory factors such as ROS and the cytokines IL-12, TNF-α, and IL-6 (17) . The signals that recruit CD4 + T cells and macrophages into the PNS in inflammatory neuropathies, however, are currently unclear.
The extracellular matrix (ECM) is a prominent feature of the PNS and has been implicated in numerous developmental processes, including Schwann cell migration, radial sorting of axons, and myelination (18, 19) . In light of recent reports that found a role for ECM proteins in inflammation (20) (21) (22) (23) (24) , we investigated their possible role in the development of SAPP (7) . We found increased expression of the ECM protein periostin (POSTN) by Schwann cells in affected nerves of SAPP mice and patients with CIDP. Moreover, Postn expression aggravates neuropathy, since Postn-deficient animals have delayed disease onset and improved nerve function by both electrophysiological and pathological analChronic inflammatory demyelinating polyneuropathy (CIDP) and Guillain-Barre syndrome (GBS) are inflammatory neuropathies that affect humans and are characterized by peripheral nerve myelin destruction and macrophage-containing immune infiltrates. In contrast to the traditional view that the peripheral nerve is simply the target of autoimmunity, we report here that peripheral nerve Schwann cells exacerbate the autoimmune process through extracellular matrix (ECM) protein induction. In a spontaneous autoimmune peripheral polyneuropathy (SAPP) mouse model of inflammatory neuropathy and CIDP nerve biopsies, the ECM protein periostin (POSTN) was upregulated in affected sciatic nerves and was primarily expressed by Schwann cells. Postn deficiency delayed the onset and reduced the extent of neuropathy, as well as decreased the number of macrophages infiltrating the sciatic nerve. In an in vitro assay, POSTN promoted macrophage chemotaxis in an integrin-AM (ITGAM) and ITGAV-dependent manner. The PNS-infiltrating macrophages in SAPP-affected nerves were pathogenic, since depletion of macrophages protected against the development of neuropathy. Our findings show that Schwann cells promote macrophage infiltration by upregulating Postn and suggest that POSTN is a novel target for the treatment of macrophageassociated inflammatory neuropathies.
the perineurium of NOD.WT nerves ( Figure 1I , top left), whereas POSTN immunoreactivity was also diffusely positive in the endoneurium of affected NOD.Aire GW/+ nerves ( Figure 1I , top right). Thus, Postn mRNA and protein expression is increased in neuropathic NOD.Aire GW/+ nerves. To determine whether increased Postn expression is specific to NOD.Aire GW/+ mice, we immunostained sciatic nerves from 2 additional models of inflammatory neuropathies: (a) autoimmune peripheral neuropathy induced in immunodeficient SCID mice upon transfer of splenocytes from neuropathic NOD.Aire GW/+ mice (7) and (b) transfer of CD4 + T cells from a myelin protein zerospecific (Mpz-or P0-specific) T cell receptor-Tg mouse line (NOD. POT TCR-Tg) (44) . Reconstituted mice were sacrificed when severe neuropathy (clinical score of 3) was observed. We observed by immunohistochemistry that POSTN expression in sciatic nerves was increased in both of these models ( Figure 1I , bottom 2 images), suggesting that induction of Postn is not unique to NOD. Aire GW/+ mice, but is a more generalizable feature of inflammatory peripheral neuropathies in mice. Interestingly, we observed no change in the expression of Postn 3 days after axotomy (Supplemental Figure 3 ), suggesting that Postn upregulation in the PNS may be specific to inflammatory neuropathies. Finally, to determine whether POSTN is upregulated in human CIDP, we immunostained nerve biopsies from 5 patients with CIDP and 5 patients with axonal (noninflammatory) neuropathy. We detected POSTN expression in 2 of the 5 CIDP patients' samples, but not in the samples from the patients with axonal neuropathy ( Figure 1J ). Therefore, POSTN upregulation is a feature of inflammatory neuropathy in both mice and humans.
Schwann cells express Postn during SAPP. To identify the cells expressing Postn, we generated NOD Postn reporter mice, which harbor a Postn allele into which a lacZ cassette is targeted (45) . We performed histochemistry for β-gal using X-gal as a substrate (46) on nerves from neuropathic NOD.Aire GW/+ and age-matched NOD.WT mice that were heterozygous for this Postn allele (Postn lacZ/+ ). In NOD.WT Postn lacZ/+ mice, X-gal crystals were restricted to the perineurium of sciatic nerves ( Figure  2A , top left), but in severely neuropathic (clinical score of 3) NOD.Aire GW/+ Postn lacZ/+ mice, X-gal crystals were also prominent in the endoneurium (Figure 2, A and B) . In parallel, we used adoptive transfer (AT) of splenocytes from neuropathic NOD.Aire GW/+ mice to induce neuropathy in T and B celldeficient NOD.SCID Postn lacZ/+ recipients; in reconstituted mice, non-T and non-B cell lineages derived from NOD.SCID hosts harbor the Postn reporter allele. Sciatic nerves from NOD.SCID Postn lacZ/+ recipient mice were examined when severe neuropathy (clinical score of 3) was observed and were compared with unreconstituted NOD.SCID Postn lacz/+ control mice. In the AT model, we observed β-gal activity in a pattern that was similar to that of the spontaneous NOD.Aire GW/+ model. Namely, in unreconstituted, non-neuropathic control mice, we found that β-gal activity was absent in the endoneurium and was only seen in the perineurium. On the other hand, in reconstituted, neuropathic recipient mice, we found that β-gal activity was present in the endoneurium (Figure 2 , A and B, bottom), confirming that endoneurial Postn expression was associated with neuropathy development and demonstrating that nonlymphocytes expressed Postn.
ysis. Additionally, Postn-deficient sciatic nerves show reduced infiltration of both T cells and macrophages. Macrophages, but not T cells, migrated across a Transwell membrane in response to POSTN, suggesting that POSTN primarily induces macrophage chemotaxis. Finally, macrophages recruited to affected sciatic nerves are pathogenic, as macrophage-depleted animals showed delayed disease onset and improved nerve function. Overall, our results demonstrate that Schwann cell-derived POSTN promotes neuropathy pathogenesis by directly recruiting pathogenic macrophages to the PNS.
Results
Postn expression is induced during SAPP. To investigate a possible role for ECM proteins in the development of inflammatory neuropathy, we used a strain of NOD mice that develops SAPP, owing to a dominant, loss-of-function G228W mutation in the autoimmune regulator gene (NOD.Aire GW/+ mice) (7) . PNS autoimmunity in NOD.Aire GW/+ mice shares key features with human CIDP, including infiltration of peripheral nerves by CD4 + T cells and F4/80 + macrophages (25) (26) (27) , IFN-γ production by CD4 + T cells (28, 29) , and peripheral nerve demyelination (7, 30) . We screened mRNA levels of 6 ECM genes with known roles in PNS development: laminin a2 (Lama2) (31) , laminin a4 (Lama4) (31) , laminin a5 (Lama5) (32) , laminin b1 (Lamb1) (31), thrombospondin 2 (Thbs2) (33) , and Postn (34, 35) . We used quantitative reverse transcription PCR (qRT-PCR) to compare the relative expression levels of these genes between sciatic nerves from age-matched WT (NOD. WT) mice and those of affected NOD.Aire GW/+ mice. Sciatic nerves from NOD.Aire GW/+ mice were harvested when severe neuropathy (clinical score of 3 out of a maximum of 4) was observed. While the levels of Lama2, Lama4, Lama5, and Lamb1 mRNA showed no change ( Figure 1, A-D) , the levels of Thbs2 and Postn were significantly increased in neuropathic NOD.Aire GW/+ mice compared with levels in NOD.WT mice (Figure 1 , E and F). Increased Thbs2 expression with PNS inflammation was not surprising, given previous reports that Thbs2 expression increases after nerve injury and that Thbs2 may play a role in axonal regeneration (36) . However, increased Postn expression was unexpected, since it has not been previously linked to peripheral nerve injury or inflammation.
A member of the fasciclin family, Postn is widely expressed during embryonic development (34, (37) (38) (39) (40) . POSTN promotes cell motility through interaction with integrins (41, 42) and has been linked to several inflammatory diseases (20) (21) (22) 43) , making it an intriguing target to investigate. Increased Postn expression was associated with neuropathy, since 8-week-old preneuropathic mice expressed similar levels of Postn mRNA compared with levels in NOD.WT mice (Supplemental Figure 1 ; supplemental material available online with this article; https://doi.org/10.1172/ JCI99308DS1). To examine POSTN expression in SAPP, we used Western blotting and immunostaining to characterize POSTN protein expression in the PNS of neuropathic mice. Western blot analysis showed significantly increased POSTN protein in whole sciatic nerves from neuropathic NOD.Aire GW/+ mice compared with nerves from NOD.WT mice (Figure 1 , G and H). We verified that this 75-kDa band corresponded to POSTN, since it was absent in Postn-deficient mice (Supplemental Figure 2) . Immunostaining showed that POSTN immunoreactivity was mostly restricted to 4 7 2 9 jci.org Volume 128 Number 10 October 2018
Nerve sections from NOD.SCID Postn +/+ recipient mice did not exhibit X-gal crystals, even in regions with reduced numbers of myelinated axons (Supplemental Figure 5) , demonstrating that X-gal crystals are specific to the lacZ transgene. Together, these findings indicate that X-gal crystals seen in Schwann cells and non-Schwann endoneurial cells of neuropathic NOD.Aire GW/+ mice reflect Postn reporter expression.
To confirm that Schwann cells are a source of increased Postn expression in neuropathic nerves, we measured relative Postn mRNA expression by qRT-PCR in flow-sorted live CD45 -
CD3
-p75 + (p75 + ) Schwann cells (gating strategy in Supplemental Figure 6 ). In NOD.WT mice, in which neuropathy is absent, this cell population consists of nonmyelinating Schwann cells (47) . In neuropathic NOD.Aire GW/+ mice, on the other hand, this cell population probably also contains denervated (48, 49) and promyelinating (50) Figure 2F ). Since X-gal crystals Light microscopic analysis of semithin sections of epoxyembedded nerves from both neuropathic NOD.Aire GW/+ and NOD. SCID Postn lacz/+ AT recipient mice revealed diffuse endoneurial β-gal activity as well as areas of intense β-gal activity ( Figure 2B ). We next used electron microscopy (EM) to characterize the cell types expressing Postn in the endoneurium of neuropathic nerves. EM revealed that X-gal crystals were in neuropathic NOD.Aire GW/+ Schwann cells, which was inferred by their physical relationships with axons ( Figure 2 , C and D, top panels). We observed a similar pattern in nerves from reconstituted, neuropathic NOD.SCID Postn lacZ/+ recipient mice ( Figure 2 , C and D, bottom, and Figure 2E ). We observed X-gal crystals in promyelinating Schwann cells that ensheathed large axons ( Figure 2C ), nonmyelinating Schwann cells associated with many small, unmyelinated axons ( Figure 2D ), and normal-appearing, myelinating Schwann cells ( Figure 2E ). We also observed X-gal crystals in endoneurial cells with features distinct from those of Schwann cells (Supplemental Figure 4) . To rule out the possibility that X-gal crystals were a nonspecific staining artifact independent of the lacZ transgene, we performed histochemistry for β-gal on NOD.SCID mice lacking the Postn lacZ reporter. Postn deficiency delays the onset of neuropathy. Mice homozygous for the Postn lacZ reporter allele also lack functional Postn expression, because the β-gal cassette replaces exons 4-10 of samples with antibodies against POSTN and the Schwann cell marker S100B ( Figure 2G ). We observed prominent overlap between POSTN and S100B, indicating that Schwann cells are the source of POSTN in human CIDP patients as well as in murine SAPP. As a complementary approach, we sought to determine whether a HSC line can be induced to express POSTN. It has been reported that Neuregulin 1 (NRG1) and TGF-β can induce Postn expression in cultured rat Schwann cells (35) . Further, Tgfb is highly expressed in the sciatic nerve of SAPP mice (Supplemental Figure 7) , suggesting its presence at the site of inflammation. Moreover, infiltrating CD4 + T cells express high levels of Tgfb (data (J) Infiltration scores were assigned as follows: 0 = no infiltration; 1 = 1%-25% of the nerve was infiltrated; 2 = 26%-50% of the nerve was infiltrated; 3 = 51%-75% of the nerve was infiltrated; 4 = 76%-100% of the nerve was infiltrated. Each dot represents an individual mouse. *P < 0.05 and **P < 0.005, by log-rank test (A), 2-tailed, unpaired t test with Welch's correction (C-E and G), or Fisher's exact test (J). jci. Figure 8A ), electrophysiologically (Supplemental Figure 8 , B-E), or anatomically (Supplemental Figure 8, F-H) . Thus, genetic Postn deficiency in mice does not alter PNS structure or function or preclude the use of Postn-deficient mice to probe the role of Postn in PNS autoimmunity.
To undertake these studies, we used the AT model of inflammatory neuropathy, in which splenocytes from Postn-sufficient, neuropathic NOD.Aire GW/+ mice were transferred into Postndeficient NOD.SCID recipients (NOD.SCID Postn Figure 9) , suggesting that heterozygosity for the mutant Postn allele does not have a functional consequence. In contrast, we found that NOD.SCID Postn -/-recipient mice were protected from neuropathy, since splenocyte transfer provoked neuropathy in only 40% of NOD.SCID Postn -/-recipients by 12 weeks after transfer ( Figure 3A) . Thus, Postn deficiency in non-T and -B cells ameliorates clinical neuropathy.
To further characterize PNS disease in these mice, we performed electromyography (EMG) on recipients 10 weeks after AT, or earlier, if moderate or severe neuropathy (clinical score of 3) was noted. The 10-week time point was chosen, because most Postn-sufficient recipient mice develop neuropathy by this time. EMG revealed that Postn-sufficient recipients had significantly reduced compound muscle action potential (CMAP) peak amplitudes ( Figure 3 , B and C), slower conduction velocities ( Figure  3D ), and increased CMAP duration ( Figure 3 , B and E) compared with NOD.SCID Postn -/-recipient mice 10 weeks after AT. The combination of increased CMAP durations and reduced conduction velocities suggested that more axons were demyelinated in the Postn-sufficient recipient mice. To investigate this point, we examined sciatic nerves by light microscopy (semithin sections) and EM (thin sections) and found larger regions of demyelinated axons in Postn-sufficient recipients compared with Postn- Figure 3 , F and H). In order to quantify demyelination, we compared the density of myelinated axons in tibial nerve cross sections. As expected, the number of myelinated axons/1,000 μm 2 was significantly lower in Postn-sufficient AT recipient mice than in Postn-deficient mice ( Figure 3G ). In addition to demyelination, other factors such as edema and immune cell infiltration may contribute to the decreased myelinated nerve density observed in neuropathic animals. Indeed, the regions of demyelinated axons contained many cells that were not surrounded by a basal lamina and had the ultrastructural fea- . Each dot represents an individual mouse. *P < 0.05, **P < 0.005, ***P < 0.0005, and ****P < 0.0001, by 2-tailed t test with Welch's correction (A-E), log-rank test (J), or ordinary 1-way ANOVA with Tukey's post hoc test for multiple comparisons (L-N) Figure 14) ; however, we detected a significant increase in the M1-associated markers Cxcxl9, Cxcl10, and Tnfa and the M2-associated markers Arg and Tgfb (Figure 6, A-E Figure 6H ), which may reflect an upregulation of MHCII expression by other cell types such as Schwann cells (51) (52) (53) . These data suggest that nerve-infiltrating macrophages are heterogeneous, expressing both M1-and M2-associated markers, and express markers of activation.
Since nerve-infiltrating macrophages express both M1-and M2-associated markers, we wondered whether POSTN attracts macrophages of a specific phenotype. POSTN has been suggested to recruit M2 antiinflammatory macrophages (54), but whether POSTN also recruits the M1 macrophage subtype is unclear. To test this, macrophages were skewed toward an M1 or M2 phenotype prior to inclusion in a Transwell migration assay. Unskewed, and M1-and M2-skewed macrophages all migrated to a similar degree in response to POSTN ( Figure 6I ), indicating that POSTN is a chemotactic factor for both M1 and M2 macrophages. It has also been reported that POSTN can regulate the expression of markers of M1 and M2 polarization (54) . To determine whether POSTN alters macrophage polarization, we skewed macrophages toward an M1 or M2 phenotype in the presence or absence of POSTN and measured the expression of M1 and M2 markers by qRT-PCR. POSTN did not change the expression of the M1-associated markers Tnfa and iNos or the M2-associated marker Arg (Supplemental Figure 15) . Thus, POSTN does not impact macrophage polarization in vitro.
Next, to determine whether macrophages contribute to SAPP, we treated NOD.Aire GW/+ mice between 7 and 14 weeks of age with clodronate liposomes to deplete phagocytic cells. Uptake of clodronate liposomes by phagocytes induces their apoptosis, and clodronate liposomes have previously been used to deplete macrophages in autoimmune mouse models (55-58). As expected, fewer F4/80 + CD11b
+ macrophages were noted in the spleens of mice 3 days after treatment with clodronate compared with vehicle control liposome numbers (Supplemental Figure 16) . Clodronate treatment was associated with a significant delay in the onset of peripheral neuropathy in NOD.Aire GW/+ mice compared with vehicle liposome treatment (Supplemental Figure 17A) . POSTN promotes macrophage chemotaxis. Reduced T cell and macrophage numbers in the sciatic nerve of Postn-deficient AT recipient mice could be the result of reduced proliferation, reduced T cell activation, or increased cell death. If Postn deficiency impacts T cell or macrophage proliferation or death, one would expect to see fewer T cells and macrophages in the spleens of Postn-deficient mice. However, we observed no difference in the frequency or total number of CD3 + , CD4 + , or CD8 + T cells or CD11b + macrophages (Supplemental Figure 11) . Additionally, the frequency and number of Ki67 + T cells (Supplemental Figure 12 , A-C) and macrophages (Supplemental Figure 12, Figure 12 , G-K). Finally, we detected no difference in the expression of the apoptotic regulator Bcl2 in macrophages treated in vitro with POSTN (Supplemental Figure 13) . Taken together, these data suggest that reduced numbers of T cells and macrophages in the sciatic nerves of Postn-deficient AT recipients cannot be explained by altered immune cell proliferation, activation, or death.
Another possible explanation for decreased T cell and macrophage nerve infiltration in Postn-deficient mice is that POSTN normally promotes the migration of these immune cell types into the PNS. We used a Transwell system ( Figure 5A ) to test the ability of CD4 + T cells or macrophages to migrate toward increasing concentrations of POSTN protein. POSTN failed to induce the migration of CD4 + T cells that were isolated from the spleens of neuropathic NOD.Aire GW/+ mice, regardless of the concentration of POSTN ( Figure 5B) . However, the migration of RAW cells, a macrophage-derived cell line, was increased in response to POSTN in a dose-dependent manner ( Figure 5C ). We observed similar results when NOD.Aire GW/+ bone marrow-derived macrophages were used in place of RAW cells ( Figure 5D ). Known POSTN receptors include the integrins ITGAV (42) and ITGAM (CD11b) (41) , which have been implicated in mediating various POSTN-dependent effects, and macrophages in infiltrated sciatic nerves express both CD11b (also known as ITGAM) ( Figure 4G ) and ITGAV ( Figure 5E ). Inclusion of blocking antibodies specific to CD11b/ITGAM or ITGAV in the upper chamber of the Transwell prevented RAW cells and NOD.Aire GW/+ bone marrow-derived macrophages from migrating across the membrane, whereas IgG isotype control antibodies did not (Figure 5, F and G ). These data demonstrate that POSTN is directly chemotactic to macrophages but not T cells and that this response requires ITGAV and ITGAM.
Macrophages promote the development of PNS autoimmunity. While macrophages are a predominant cell type in the immune cell infiltrate of neuropathic nerves, their role in the development of autoimmune peripheral neuropathy is unclear. To address jci.org Volume 128 Number 10 October 2018
While both T cell and macrophage numbers were reduced in peripheral nerves of Postn-deficient mice, only macrophages responded to POSTN in an in vitro Transwell migration assay. This finding suggests that POSTN primarily promotes macrophage chemotaxis and does not directly promote T cell chemotaxis. Instead, POSTN may promote T cell influx indirectly through the recruitment of macrophages that in turn express T cell chemoattractants. This notion is consistent with our observation (Figure 6 , A and B) that nerve-infiltrating macrophages express the T cell chemoattractants Cxcl9 and Cxcl10. Additionally, POSTN has been re ported to regulate other T cell chemoattractants including RANTES (22, 66) , which is secreted by macrophages during EAN (9) , and the chemokine ligand CCL17 (21) . Thus, we propose that a positive feedback loop exists between T cells and macrophages. This cycle is probably initiated by PNS-specific CD4 + T cells, given our data that CD4 + T cells are sufficient to incite SAPP in immunodeficient mice (7) . These early infiltrating T cells produce TGF-β, which induces Schwann cells to express Postn. By binding to ITGAM and ITGAV on macrophages, POSTN attracts macrophages into the endoneurium. This amplifies a positive feedback loop between macrophages and T cells through increased macrophage expression of the T cell chemoattractants Cxcl9 and Cxcl10 (Supplemental Figure 18) .
In mouse and rat models of nerve injury, macrophages are recruited 3-5 days after injury (67) . In this setting, macrophages are important in clearing myelin debris and participate in nerve regeneration by secreting growth-promoting factors and cytokines that act upon Schwann cells and neurites (68) . Given this reparative role for macrophages during axotomy, the promotion by Postn of macrophage infiltration may have both proinflammatory and reparative effects. Further, it is also possible that Postndependent macrophage infiltration may even be antiinflammatory, since nerve-infiltrating macrophages express some immunosuppressive M2-associated markers, and data from our group and others show that Postn can promote M2 macrophage chemotaxis (54). Our results indicate that macrophages overall were proinflam matory during PNS autoimmunity, since macrophage depletion delayed the onset of disease. Nevertheless, it is important to acknowledge that the macrophage population is likely to be heterogeneous (69), since both M1-and M2-associated markers were expressed ( Figure 6 , A-E), and that a subset of PNSinfiltrating macrophages may ameliorate disease. Further delineation of macrophage subsets and their function in SAPP will be the subject of future studies.
In addition to SAPP and axotomy, other disease states, including some hereditary neuropathies, are also associated with macrophage infiltration into the PNS (70) . At present, it is not clear whether the same chemotactic factors mediate macrophage influx in each of these conditions. Multiple factors, such as CCR2-CCL2 interactions, have been implicated in macrophage recruitment after nerve injury (71) . CCR2 is expressed on infiltrating macrophages, and CCL2 (also known as MCP) secretion by Schwann cells recruits macrophages into the injured nerve (72) (73) (74) . Additionally, MIP1A and IL-1β also play important roles in macrophage chemotaxis with axotomy (72) . Whether POSTN also plays a role in macrophage infiltration with hereditary neuropathies and whether CCR2-CCL2, MIP1A, and IL-1β might promote macro phage infiltration during autoimmune peripheral neuropathy await further investigation.
of CD11b + F4/80 + macrophages in the sciatic nerves of clodronate liposome-treated mice. Thus, clodronate treatment protects against SAPP through macrophage depletion (Supplemental Figure 17, B and C) . In parallel, we investigated whether macrophage depletion was similarly protective in the AT model of inflammatory neuropathy. We administered clodronate or vehicle liposomes to reconstituted NOD.SCID recipients from 5 weeks after transfer until the mice developed neuropathy or were used in further experiments. The onset of clinical neuropathy in reconsti tuted recipients was significantly delayed with clodronate compared with vehicle liposome treatment ( Figure 6J ). Moreover, nerve conductions performed 5 weeks after administering clod ronate (10 weeks after administration of splenocytes) ( Figure 6 , K-N) showed increased CMAP peak amplitudes ( Figure 6L ), decreased CMAP durations ( Figure 6M ), and faster nerve conduction velocities ( Figure 6N ) with clodronate treatment. Thus, in the AT model, clodronate-mediated depletion of macrophages protects against the development of demyelinating neuropathy, which suggests a pathogenic role for macrophages in inflammatory neuropathy.
Discussion
The development of tissue-specific autoimmunity involves a complex interplay between autoreactive immune cells and the target tissue. Whether the PNS regulates disease progression in autoimmune neuropathies, however, has not been documented. We show here that Schwann cells participate in the immune response by upregulating the ECM protein POSTN. Postn expression was increased in multiple mouse models of CIDP, suggesting that this may be a generalizable finding in inflammatory neuropathies. The absence of Postn delayed the onset of disease and reduced the severity of neuropathy. Postn deficiency also resulted in improved nerve function by EMG and reduced immune cell infiltration into nerves. Together, these findings suggest that Schwann cell-derived POSTN promotes PNS autoimmunity by enhancing immune cell infiltration (Supplemental Figure 18) .
Postn is upregulated in various diseases and injuries (59) including cancer (60), myocardial infarction (61), asthma (62), skin inflammation (21), glomerulonephritis (22) , and colitis (43). TGF-β or neuregulin/ERBB3 signaling (35, 63) can induce Postn expression in Schwann cells during development; additionally, Postn expression can also be induced by IL-4 and IL-13 in keratinocytes during allergic skin inflammation (21) and by TNF-α and IL-17 during liver fibrosis (64) . POSTN signals through ITGAV/ B3 (21, 42) , ITGAV/B5 (42), and ITGAM (eosinophils) (41) and results in the phosphorylation of focal adhesion kinase (FAK) (65) and AKT (65) in neurons and the activation of NF-κB (21, 43) in keratinocytes and colon. POSTN regulates various cytokines and chemokines including TNF-α in skin inflammation and following spinal cord injury (21, 23) ; IL-1A, granulocyte-macrophage-CSF (GM-CSF), and the chemokine ligand CCL17 in allergic skin inflammation and glioblastoma (21, 54) ; RANTES (CCL5) in kidney and nasal epithelia (22, 66) ; and CCL2, CCL4, CCL7, and CXCL2 in pulmonary fibrosis (20) . Additionally, POSTN has been shown to promote immune cell recruitment to sites of inflammation in spinal cord injury and glioblastoma (20, 23, 54) . We observed a similar effect of POSTN on the recruitment of immune cells to the sciatic nerve during SAPP. jci.org Volume 128 Number 10 October 2018
Evaluation of SAPP. Mice were evaluated weekly (spontaneous model) or every other day (AT model) for clinical signs of neuropathy, which was scored as follows: 0 = no signs of neuropathy present; 1 = mild hind limb weakness; 2 = pronounced bilateral hind limb weakness; 3 = reduced or absent ability to grip cage grating; and 4 = moribund. For the neuropathy incidence curve, mice were considered neuropathic when they reached a score of 2 in order to limit the effect of false positives. SAPP was confirmed by electromyography, which was performed as previously described (81, 82) .
Surgery. Mice were anesthetized with isoflurane and 100 mg/kg ketamine/10 mg/kg xylazine or 250 mg/kg avertin. Fur was removed from the surgical area with depilatory cream and cleaned with alcohol wipes. The sciatic nerve was exposed and transected at the sciatic notch. The contralateral nerve was exposed but left intact (mock). The wound was sealed with surgical glue. Meloxicam (10 mg/kg) was administered at the time of surgery, and 2 mg/kg meloxicam was administered daily following surgery for pain management. Three days after nerve transection surgery, nerves were harvested, frozen in liquid nitrogen, and stored at -80°C until use. RNA was extracted from transected and mock nerves, and Postn levels were measured by qRT-PCR.
Flow cytometry
Nerve digestion. Nerves were chopped into segments with a razor blade and digested in PBS containing 1 mg/ml collagenase and 1% FBS at 37°C for 30 minutes with periodic agitation. Part way through the digestion, the sample was triturated with a 20-gauge needle to aid in tissue disruption. Dissociated nerves were filtered through a 40-μm mesh and washed prior to use in experiments.
Antibodies. CD3 (clone 145-2C11), CD4 (clone RM4-5), CD8 (clone 53-6.7), F4/80 (clone BM8), and CD45 (clone 30F11) antibodies were purchased from eBioscience. CD11b (clone M1/70) was purchased from BioLegend. Live/Dead Fixable Yellow Dye (Life Technologies, Thermo Fisher Scientific) was used to exclude dead cells. Rabbit anti-p75 (1:500) was purchased from Abcam, and DyLight 488-conjugated goat antirabbit IgG (1:500) was purchased from Thermo Fisher Scientific.
Staining. Single-cell suspensions were washed twice with FACS buffer. Fc receptors were blocked by incubating cells with supernatant from a 2.4G2 hybridoma for 10 minutes. Cells were stained for 30 minutes on ice and washed prior to analysis.
Analysis. Samples were run on a Beckman Coulter CyAn ADP or BD LSR II flow cytometer and analyzed using FlowJo software. A BD FACSAria II was used for sorted samples.
Immunostaining
Mouse tissues. Nerves from NOD.Aire GW/+ and NOD.WT mice were embedded in OCT and frozen at -20°C for 2 hours prior to storage at -80°C. Sciatic nerve cross sections or longitudinal sections (6-μm) were fixed with cold acetone, blocked with 2.5% goat serum, and stained with 10 μg/ml anti-periostin (Abcam), anti-F4/80 (eBiocience), and anti-CD3 (BioLegend) for 2 hours. After washing with PBS containing 0.1% Tween (PBST), sections were incubated with anti-rat-HRP or anti-rabbit-HRP (VECTOR Laboratories) antibody for 30 minutes and developed in DAB solution until the desired stain intensity was achieved. All sections were processed in parallel, including the same length of time in the DAB solution. Samples were imaged on a Nikon Eclipse 80i wide-field microscope.
Human tissues. Slide-mounted cryosections of sciatic nerves from deidentified CIDP patients were air dried and fixed with 2% paraforIn the CNS, Postn is expressed by several glial cell types including astrocytes (65) and pericytes (23) following injury. Postn promotes scar formation, regulates blood-brain barrier permeability, and induces proinflammatory molecules such as MMP9, leading to impaired functional recovery following spinal cord injury (23) and increased pathology following subarachnoid hemorrhage (75) . In contrast to the CNS, we did not observe increased Postn expression following PNS injury. The regenerative capacity of the PNS is markedly better than that of the CNS; however, the underlying reasons for this difference in regenerative capacity are poorly understood. Since Postn deficiency improves recovery following CNS injury, we speculate that a lack of Postn upregulation following PNS injury may partially account for the improved ability of the PNS to repair itself.
In preclinical trials, POSTN inhibitors have shown promise as cancer therapeutics, and both antibody-based and aptamer POSTN inhibitors are actively being pursued (76, 77) . Our finding that POSTN is induced in mouse models of inflammatory neuropathy and required for macrophage-mediated disease acceleration suggests that POSTN inhibition may be a potential immunotherapeutic strategy for inflammatory neuropathies. Since POSTN recruits macrophages to the PNS through interaction with ITGAV, targeting ITGAV is another potential strategy implicated by our results. Currently, several antibody and small-molecule inhibitors of ITGAV are in phase I and phase II clinical trials for the treatment of cancer (78, 79) . Our results provide a basis for the development of these molecules as novel therapeutics for inflammatory neuropathies.
Methods

Animals
Strains and housing. Mice were housed in a specific pathogen-free facility at the UNC-CH. NOD.Aire GW/+ and myelin protein zero T cell receptor-Tg (NOD.P0T) mice were generated as previously described (44, 80 AT model. Forty-eight-well plates were coated with anti-CD3 (eBioscience, clone 145-2C11; 1 μg/ml in PBS) and anti-CD28 (BD Pharmingen, clone 37.51; 1 μg/ml in PBS) overnight at 4°C or for at least 2 hours at 37°C and washed with PBS. Splenocytes from neuropathic NOD.Aire GW/+ or NOD.P0T mice were plated at a density of 10 6 (NOD.
Aire GW/+
) or 5 × 10 5 (P0T) cells/well and cultured for 96 to 120 hours in DMEM supplemented with 10% FBS, 10 mM HEPES buffer (NOD.P0T mice only), penicillin-streptomycin (100 U/ml, Gibco, Thermo Fisher Scientific), and 2-mercaptoethanol (55 μM). Activated splenocytes (1 × 10 6 ) were harvested, washed once with sterile PBS, and adoptively transferred in sterile PBS using retro-orbital injection into immunodeficient NOD.SCID recipients sedated with 2% isoflurane in oxygen. jci.org Volume 128 Number 10 October 2018
Macrophage skewing Bone marrow-derived macrophages were seeded at 250,000 cells/ well in 24-well plates in DMEM medium containing 10% FBS and 1% penicillin-streptomycin. LPS (100 ng/ml) and IFN-γ (25 ng/ml) were added to the media for M1 differentiation, and IL-4 (25 ng/ml) was added to the media for M2 differentiation. After 24 hours in skewing conditions, 100 ng/ml POSTN was added to some of the cultures, and the macrophages were cultured for another 24 hours. Total RNA was extracted from the macrophages and used in qRT-PCR analyses. Cxcl9, Cxcl10, Cd86, iNos, Il12, and Tnfa were used as M1 markers, and Il10, Ym1, Arg1, Fizz, and Mrc were used as M2 markers.
HSC culture and stimulation
Immortalized HSCs were cultured as described previously (84) . HSCs were grown to 80% confluence and seeded into 12-well plates at a density of 250,000 cells in 2 ml growth media per well. After 24 hours at 37°C in a humidified 5% CO 2 incubator, serum-free media were used and cells were treated with 1 ng/ml TGF-β (STEMCELL Technologies), 10 ng/ml NRG1 (Thermo Fisher Scientific), or both for 24 hours at 37°C with 5% CO 2 . Postn expression was measured by qRT-PCR. 
Quantitation of demyelination
Semithin sections of tibial nerve stained with 1% paraphenylenediamine were analyzed using Fiji software (ImageJ, NIH). The area of each tibial nerve was determined on the basis of the inner edge of the perineurium. The total number of myelinated axons in each cross section was counted manually using Fiji software to mark each myelinated axon. The following formula was used to determine the number of maldehyde (PFA), washed in PBS, and permeabilized with 0.2% Triton X-100. volume of 250 μl. Transwell inserts with 8-μm pores (Corning) were used. Recombinant POSTN (R&D Systems) was added to the lower chamber at 50, 100, 200, 500, and 1,000 ng/ml in DMEM with 5% FBS. Anti-CD11b (Thermo Fisher Scientific) and anti-CD51 (ITGAV) (BD) antibodies were added into the upper chamber at a concentration of 10 μg/ml. For experiments comparing M1 and M2 macrophages, 200,000 bone marrow-derived macrophages were seeded in the upper chamber of the Transwell in a total volume of 350 μl. Macrophages were incubated with or without macrophage-skewing conditions for 24 hours, and then the upper chamber was changed to serum-free DMEM culture medium, and the lower chamber was changed to DMEM with 5% FBS, with or without 100 ng/ml POSTN. Cells were allowed to migrate through the Transwell insert membrane for 24 hours. The inserts were removed, fixed in cold methanol, and stained with methanol containing 1% crystal violet. The inside of the Transwell was swabbed thoroughly with cotton swabs and air dried at room temperature overnight. 
Western blot analysis
Whole sciatic nerves were homogenized in Laemmli buffer. Proteins were separated by SDS-PAGE and Novex NUPAGE 4%-12% Bis-Tris Gel (Life Technologies, Thermo Fisher Scientific) and transferred onto methanolactivated PVDF membranes (Thermo Fisher Scientific). The blot was blocked with 5% nonfat dry milk in TBS for 1 hour at room temperature and subsequently incubated overnight at 4°C with polyclonal anti-POSTN (Abcam) diluted to 1:5,000 in TBS with 0.01% TBS Tween-20 (TBST) and 5% nonfat dry milk. Blots were washed, incubated with 1:10,000 HRP-conjugated goat anti-rabbit antibody (Abcam) in blocking buffer for 1 hour at room temperature, and washed again. Blots were developed by SuperSignal West Femto Maximum Sensitivity Substrate and exposed to x-ray film. GAPDH was used as a loading control. After 3 washes for 10 minutes with TBST and 1 wash for 5 minutes in TBS, the blot was incubated with HRP-conjugated mouse anti GAPDH antibody (Thermo scientific) diluted to 1:1,000 for 1 hour at room temperature. The blot was washed and developed by SuperSignal West Femto Maximum Sensitivity Substrate and exposed to x-ray film or imaged with a Bio-Rad ChemiDoc.
Statistics
Statistics were performed with GraphPad Prism software or R. For neuropathy incidence curves, a log-rank (Mantel-Cox) test was used. An unpaired, 2-tailed t test was used when comparing 2 groups with continuous values. Welch's correction was applied when the standard deviation was different for each group. For discrete data, Fisher's exact test was performed in R. ANOVA with multiple comparisons was used when comparing 3 or more groups. A paired t test was used when experimental and control samples were obtained from the jci.org Volume 128 Number 10 October 2018
